Bintai Kinden’s partner files trademark for Covid-19 vaccine


KUALA LUMPUR: Bintai Kinden Corporation Bhd’s partner Generex Biotechnology Corporation has filed for a trademark for its li-Key vaccine and patent for its Ii-Key-SARS-CoV-2 vaccine.

In a statement issued on Thursday, Bintai Kinden said the Ii-Key vaccine was designed to be a complete vaccine for the Covid-19.

“The technology offers the safest and best route for the rapid development of a Covid-19 vaccine, ” it said.

It explained the complete vaccine is designed to regulate the immune system to provide a targeted, neutralising antibody response.

Bintai Kinden managing director Ong Choon Lui said Generex’s Covid-19 vaccine was based on the results of the ex-vivo human studies. It will be formulated for phases one and two clinical trials.

The statement also said Generex’s subsidiary NuGenerex Immuno-Oncology Inc is exploring opportunities to deploy the targeted Covid-19 vaccine as a universal booster for RNA, DNA, and inactivated virus vaccines that contain the entire spike protein and have the potential to elicit off-target and over-active immune responses.

Bintai Healthcare Sdn Bhd was granted the exclusive rights from Generex and NuGenerex to distribute, sell and commercialize the Covid-19 vaccine in Malaysia, Brunei, Myanmar, Cambodia, Timor-Leste, Indonesia, Laos, the Philippines, Singapore, Thailand and Vietnam.

It has also been given the first right of refusal to distribute and market the vaccine within Australia, New Zealand and the global halal market.

https://www.generex.com/covid-19

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

78% readers found this article insightful

Next In Business News

Tenaga forecasts rebound in revenue
Mustapa: 12th Malaysia Plan to be tabled when Parliament reconvenes
Biggest players in short-selling are getting a pass
Nothing the stock market does ever scares retail daredevils
US Senate passes US$1.9 trillion relief bill
AirAsia Group plans air taxi, drone delivery service
Tengku Zafrul: Govt tapping into more data for effective aid
AirAsia recovering well via digital transformation
Texas grid operator made $16bil price error during winter storm, watchdog says
CPO futures to see quiet trading next week

Stories You'll Enjoy


Vouchers